Researchers at National Taiwan University have uncovered, for the first time at atomic resolution, how the human proteasome ...

A team of researchers from Academia Sinica and National Taiwan University has identified the Drosophila Cul2 substrate ...

GSK plc will present new data from its haematology portfolio at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition (6 - 9 December), reinforcing its potential to redefine ...

As we get older, our brains start to change in ways that make them increasingly vulnerable to disease – and a detailed new ...

When blood cancer in children progresses particularly aggressively, it is often due to a genetic defect: a gene fusion, such ...

Many neurodegenerative diseases are characterized by impairment of protein quality control mechanisms in neuronal cells. Ineffective clearance of misfolded proteins by the proteasome, autophagy ...

Insilico's generative AI platform, Chemistry42, successfully designed a first-in-class PROTAC targeting PKMYT1 by creating an entirely new inhibitor and its complex linker, demonstrating a powerful, ...

Molecular glues are revolutionizing cancer therapy by targeting undruggable proteins for degradation, enhancing precision ...

A French-American team reports that Carba1 prevents chemotherapy-induced neuropathy in preclinical models while preserving ...

Hong Kong Department of Health approves IASO Bio’s’ Fucaso to treat relapsed or refractory multiple myeloma: Shanghai, Nanjing Friday, November 28, 2025, 14:00 Hrs [IST] IASO ...

IASO Biotechnology has received the Hong Kong Department of Health approval for its BLA submitted for the fully human ...

IASO Biotechnology ("IASO Bio"), a commercial-stage biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of novel cell therapies and biologics for ...